Laavo Clean's alcohol-free hand sanitizers had wrong benzalkonium chloride strength and were refused at US border.
What happened
FDA laboratory-tested batches of Instant Hand Sanitizer LaavoClean without Alcohol and LaavoClean KIDS without Alcohol after they were detained and refused admission at the U.S. border. The products were labeled as made at Laavo Clean's facility and to contain 0.13% benzalkonium chloride (BZK), but testing found levels outside USP limits: 0.15% for KIDS (115% of label) and 0.15% and 0.12% (92.7% of label) for the other product. FDA also placed all drugs from the firm on Import Alert 66-78.
What FDA found
Instant Hand Sanitizer LaavoClean KIDS without Alcohol labeled as 0.13% BZK tested at 0.15%, or 115% of the label claim, outside the USP limits of 93.0% to 107.0%.
FD&C Act section 501(c), 21 U.S.C. 351(c)Two batches of Instant Hand Sanitizer LaavoClean without Alcohol labeled as 0.13% BZK tested at 0.15% (above the USP limit) and 0.12% (92.7% of label, below the USP limit).
FD&C Act section 501(c), 21 U.S.C. 351(c)
What FDA wants
FDA asks for a detailed investigation into the BZK level differences, a list of raw materials and suppliers, a list and full reconciliation of batches shipped to the U.S., and complete batch records for U.S.-distributed batches. The company must respond in writing within 15 working days.
Who should pay attention
- U.S. importers and distributors of hand sanitizers
- brands that rely on Laavo Clean as a contract manufacturer
- retailers sourcing consumer antiseptic hand rubs from Mexico
This is a summary. Read the original letter on fda.gov.